Furosemide |
Lasix |
Clinical Trial: Effect of KW-3902IV in Combination with IV Furosemide on Renal Function in Subjects with CHF and Renal Impairment
This study is currently recruiting patients.
Verified by NovaCardia September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Heart Failure, Congestive Renal Insufficiency | Drug: KW-3902IV | Phase II |
MedlinePlus related topics: Heart Failure; Kidney Failure
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety Study
Official Title: Effect of KW-3902IV in Combination with IV Furosemide on Renal Function in Subjects with Congestive Heart Failure (CHF) and Renal Impairment
Expected Total Enrollment: 30
Study start: September 2005
Eligibility
Inclusion Criteria:
- Stable congestive heart failure
- Impaired renal function
- Taking oral loop diuretic
Exclusion Criteria:
- Acutely decompensated (unstable) and end stage heart failure
- Diuretics other than loop diuretics
- Pregnant or nursing
- Inability to follow instructions
- Participation in another clinical trial within past 30 days
Location and Contact Information
California
San Diego, California, United States; Not yet recruiting
Maryland
Baltimore, Maryland, United States; Not yet recruiting
Massachusetts
Boston, Massachusetts, United States; Not yet recruiting
Ayer, Massachusetts, United States; Recruiting
Michigan
Kalamazoo, Michigan, United States; Recruiting
Tennessee
Tullahoma, Tennessee, United States; Recruiting
More Information
Last Updated: September 11, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00159614
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Furosemide (Drug Digest)
- Furosemide (Cleveland Clinic)

Not Signed In -

